NCT07177976

Brief Summary

Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing. Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 17, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

October 7, 2025

Status Verified

September 1, 2025

Enrollment Period

4 months

First QC Date

September 10, 2025

Last Update Submit

October 2, 2025

Conditions

Keywords

Chest expansionpeak expiratory flow ratedyspnea

Outcome Measures

Primary Outcomes (3)

  • Chest Expansion

    Evaluation will be done using inch tape (inches) for Chest Expansion

    03 weeks

  • Peak expiratory flow rate

    Evaluation will be done by using Peak flow meter

    03 weeks

  • Dyspnea

    Evaluation will be done by using Modified Medical Research Council Dyspnea Scale (mMRC)

    03 weeks

Study Arms (2)

Group A

EXPERIMENTAL

Patients in this group will receive Pilates breathing techniques along with pharmacological management for total of 3 weeks. Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up of the participants are performing breathing exercises at home.

Procedure: Pilates Breathing Technique along with standard pharmacological management

Group B

EXPERIMENTAL

Patients in this group will receive Pursed-lip breathing along with pharmacological management for 3 weeks. Two sessions per weeek will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up of the participants that they are performing breathing exercises at home.

Procedure: Pursed-lip breathing along with pharmacological management

Interventions

Patients in this group will receive pilates breathing technique along with pharmacological management. A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose. While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles.

Group A

Patient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home. The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing. Pharmacological management: Patient will receive medications as per prescribed by pulmonologist

Group B

Eligibility Criteria

Age40 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 40-64 years
  • Both genders (male and female)
  • Grade 1-3 on mMRC scale of dyspnea
  • COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted

You may not qualify if:

  • Moderate, severe and very severe stage of COPD according to GOLD classification
  • Patients having acute exerbation of COPD
  • Patients diagnosed with acute infection
  • Patients unable to follow command and instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University College of Physical Therapy, Islamabad, 44000

Rawalpindi, 46000, Pakistan

RECRUITING

MeSH Terms

Conditions

Lung DiseasesPulmonary Disease, Chronic ObstructiveDyspnea

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesLung Diseases, ObstructiveChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, RespiratorySigns and Symptoms

Central Study Contacts

Sana Kalim, DPT

CONTACT

Zara Khalid, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized controlled trial having two groups. One group (interventional group) wil receive Pilates breathing along with pharmacological management and the other group (control group) will perform Pursed-lip breathing along with pharmacological management.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2025

First Posted

September 17, 2025

Study Start

September 15, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

October 7, 2025

Record last verified: 2025-09

Locations